Hetero Drugs Limited

Country/Region: India     State/Province: Delhi

Main Products: API, Formulation

Company Introduction
We introduce ourselves Hetero Drugs Limited, India as a group of young technocrats involved in the manufacturing of Active pharmaceutical Ingredients (APIs) and finished formulations. Hetero was established in the year of 1993 with basic strength in Research and Development. We have 12 manufacturing units in India, of which 9 manufacturing units are producing APIs and 3 manufacturing units are in finished formulations. Our facilities approved by WHO, USFDA, Spanish, ANVISA and other health authorities.HETEROs inherent strength is strong Research and Development base with total backward integration from finished dosage forms till basic intermediates which have given us a lead over most of Indian companies and we have resulted into enormous growth of the company.HETERO is the only Indian company who has widest range of products of several therapeutic categories which includes Antihypertensive, Antidepressants, Antifungal, Anti Cancer, Anti Bacterial, Cephalosporins and Anti retroviral etc. Hetero is the largest supplier of several APIs in wide range of therapeutic categories and it also has dedicated facility for manufacturing of Oncology products.Hetero Drugs Limited is a herewith enclosing our latest product lists of API, Finished formulations and also our profile for your ready reference and you can visit our website http:// to know more about our company and products.
Company Overview

Business Type: Exporter, Retailer

Year Established: 1993

Employees: 501 - 1000 People

Plant Area: 1,000-3,000 square meters

Business Information

Main Markets: South America 10% Africa 11% Eastern Asia 11% Domestic Market 11% North America 12% Eastern Europe 10% Southern Europe 10% Mid East 8% Northern Europe 12% Oceania 5%

Trade Capacity: FOB, EXW, CPT

Contract Manufacturing: OEM Service Offered

Nearest Port: India

Trade & Financial Information

Annual Revenue: US$50 Million - US$100 Million

Total Revenue: Below US$1 Million

Export Revenue: US$5 Million - US$10 Million

Annual Output: US$5 Million - US$10 Million

Registered Capital: confidential

Export Percentage: 21% - 30%

Payment Modes: USD, CAD, HKD

Lead Time: 34 days

Import/Export Mode: Using an agent

Product Showcase
API
Formulation

CL-Link > Health & Medicines in India Health & Medicines in Delhi Medicines in India Medicines in Delhi Pharmaceutical Drug in India Pharmaceutical Drug in Delhi